Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care

British Journal of Clinical Pharmacology

Volumn 77, Issue 6, 2014, Pages 1073-1082

  Payne, Rupert A ^a   Abel, Gary A ^a   Avery, Anthony J ^b   Mercer, Stewart W ^c   Roland, Martin O ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

hospital admission; multimorbidity; polypharmacy; primary care

Indexed keywords

PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY HEALTH CARE; UNSPECIFIED SIDE EFFECT; ELECTRONIC HEALTH RECORD; MIDDLE AGED; PRIMARY HEALTH CARE; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYPHARMACY; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SECONDARY CARE;

EID: 84895078434     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12292     Document Type: Article

References (32)

1. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ,. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516-1523.
2. Hovstadius B, Hovstadius K, Astrand B, Petersson G,. Increasing polypharmacy-an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010; 10: 16.
3. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B,. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380: 37-43.
4. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW,. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716-724.
5. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K,. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ 2011; 342: d3514.
6. Dequito AB, Mol PG, van Doormaal JE, Zaal RJ, van den Bemt PM, Haaijer-Ruskamp FM, Kosterink JG,. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands. Drug Saf 2011; 34: 1089-1100.
7. Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S,. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 2009; 26: 1039-1048.
8. Vik SA, Maxwell CJ, Hogan DB,. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38: 303-312.
9. Fincke BG, Miller DR, Spiro A, III, the interaction of patient perception of overmedication with drug compliance and side effects. J Gen Intern Med 1998; 13: 182-185.
10. Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M,. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging 2009; 26: 475-482.
11. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM,. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168: 1890-1896.
12. Beer C, Hyde Z, Almeida OP, Norman P, Hankey GJ, Yeap BB, Flicker L,. Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol 2011; 71: 592-599.
13. Cherubini A, Eusebi P, Dell'Aquila G, Landi F, Gasperini B, Bacuccoli R, Menculini G, Bernabei R, Lattanzio F, Ruggiero C,. Predictors of hospitalization in Italian nursing home residents: the U.L.I.S.S.E. project. J Am Med Dir Assoc 2012; 13: 84.e5-10.
14. Pozzi C, Lapi F, Mazzaglia G, Inzitari M, Boncinelli M, Geppetti P, Mugelli A, Marchionni N, Di BM,. Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study. Pharmacoepidemiol Drug Saf 2010; 19: 954-960.
15. PTI. Practice Team Information (PTI) statistics. Available at http://www.isdscotland.org/Health-Topics/General-Practice/GP-Consultations/ (last accessed 21 February 2012).
16. ISD Scotland. NHS Hospital Data Quality-Towards Better Data from Scottish Hospitals. An Assessment of SMR01 and Associated Data 2004-2006. Edinburgh: NHS National Services Scotland, 2007.
17. Diederichs C, Berger K, Bartels DB, the measurement of multiple chronic diseases-a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci 2011; 66: 301-311.
18. Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG,. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005; 165: 68-74.
19. Nobili A, Licata G, Salerno F, Pasina L, Tettamanti M, Franchi C, De VL, Marengoni A, Corrao S, Iorio A, Marcucci M, Mannucci PM,. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards the REPOSI study. Eur J Clin Pharmacol 2011; 67: 507-519.
20. Payne RA, Abel GA, Guthrie B, Mercer SW, the effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study. CMAJ 2013; 185: E221-228.
21. Perkins AJ, Kroenke K, Unutzer J, Katon W, Williams JW Jr, Hope C, Callahan CM,. Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol 2004; 57: 1040-1048.
22. Quail JM, Lix LM, Osman BA, Teare GF,. Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohorts. BMC Health Serv Res 2011; 11: 146.
23. Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA,. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65: 130-133.
24. Dalleur O, Spinewine A, Henrard S, Losseau C, Speybroeck N, Boland B,. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging 2012; 29: 829-837.
25. Wennberg D, Siegel M, Darin B, Filipova N, Russell R, Kenney L, Steinort K, Park T, Cakmakci G, Dixon J, Curry N, Billings J,. Combined Predictive Model: Final Report and Technical Documentation. London: Department of Health, New York University, The King's Fund, Health Dialogue, 2006.
26. Hutchinson AM, Milke DL, Maisey S, Johnson C, Squires JE, Teare G, Estabrooks CA, the resident assessment instrument-minimum data set 2.0 quality indicators: a systematic review. BMC Health Serv Res 2010; 10: 166.
27. Guthrie B, Payne K, Alderson P, McMurdo ME, Mercer SW,. Adapting clinical guidelines to take account of multimorbidity. BMJ 2012; 345: e6341.
28. Model of Care Polypharmacy Working Group. Polypharmacy Guidance. Edinburgh: Scottish Government, 2012.
29. Viktil KK, Blix HS, Moger TA, Reikvam A,. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63: 187-195.
30. Moen J, Norrgard S, Antonov K, Nilsson JL, Ring L,. GPs' perceptions of multiple-medicine use in older patients. J Eval Clin Pract 2010; 16: 69-75.
31. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
32. ISD Scotland. Navigator user guide: potentially preventable admissions indicator. v4.05. NHS National Services Scotland, 2010.